MSCV PIG (Puro IRES GFP) Citations (27)
Originally described in: Lowe Lab PlasmidsUnpublished
Articles Citing MSCV PIG (Puro IRES GFP)
| Articles |
|---|
| Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms. Liu P, Cheng H, Santiago S, Raeder M, Zhang F, Isabella A, Yang J, Semaan DJ, Chen C, Fox EA, Gray NS, Monahan J, Schlegel R, Beroukhim R, Mills GB, Zhao JJ. Nat Med. 2011 Aug 7;17(9):1116-20. doi: 10.1038/nm.2402. PubMed |
| A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling. Lin L, Chamberlain L, Pak ML, Nagarajan A, Gupta R, Zhu LJ, Wright CM, Fong KM, Wajapeyee N, Green MR. Cancer Discov. 2014 Oct;4(10):1168-81. doi: 10.1158/2159-8290.CD-13-0747. Epub 2014 Jul 11. PubMed |
| Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5alpha. Coren LV, Trivett MT, Jain S, Ayala VI, Del Prete GQ, Ohlen C, Ott DE. Retrovirology. 2015 Feb 7;12:11. doi: 10.1186/s12977-015-0137-9. PubMed |
| Jumonji Domain Containing Protein 6: A Novel Oxygen Sensor in the Human Placenta. Alahari S, Post M, Caniggia I. Endocrinology. 2015 Aug;156(8):3012-25. doi: 10.1210/en.2015-1262. Epub 2015 Jun 2. PubMed |
| Inhibition of PRL-2.CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth. Kostantin E, Hardy S, Valinsky WC, Kompatscher A, de Baaij JH, Zolotarov Y, Landry M, Uetani N, Martinez-Cruz LA, Hoenderop JG, Shrier A, Tremblay ML. J Biol Chem. 2016 May 13;291(20):10716-25. doi: 10.1074/jbc.M115.705863. Epub 2016 Mar 11. PubMed |
| Drug conjugated nanoparticles activated by cancer cell specific mRNA. Gossai NP, Naumann JA, Li NS, Zamora EA, Gordon DJ, Piccirilli JA, Gordon PM. Oncotarget. 2016 Jun 21;7(25):38243-38256. doi: 10.18632/oncotarget.9430. PubMed |
| Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. Alonso S, Hernandez D, Chang YT, Gocke CB, McCray M, Varadhan R, Matsui WH, Jones RJ, Ghiaur G. J Clin Invest. 2016 Dec 1;126(12):4460-4468. doi: 10.1172/JCI88152. Epub 2016 Oct 24. PubMed |
| SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy. Naumann JA, Widen JC, Jonart LA, Ebadi M, Tang J, Gordon DJ, Harki DA, Gordon PM. Bioconjug Chem. 2018 Apr 18;29(4):1111-1118. doi: 10.1021/acs.bioconjchem.7b00774. Epub 2018 Feb 19. PubMed |
| Nonspecific inhibition of erythropoiesis by short hairpin RNAs. Traxler EA, Thom CS, Yao Y, Paralkar V, Weiss MJ. Blood. 2018 Jun 14;131(24):2733-2736. doi: 10.1182/blood-2018-03-841304. Epub 2018 May 4. PubMed |
| Eomesodermin driven IL-10 production in effector CD8(+) T cells promotes a memory phenotype. Reiser J, Sadashivaiah K, Furusawa A, Banerjee A, Singh N. Cell Immunol. 2019 Jan;335:93-102. doi: 10.1016/j.cellimm.2018.11.008. Epub 2018 Dec 1. PubMed |
| MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia. Biswas M, Chatterjee SS, Boila LD, Chakraborty S, Banerjee D, Sengupta A. FASEB J. 2019 Apr;33(4):5268-5286. doi: 10.1096/fj.201801035R. Epub 2019 Jan 22. PubMed |
| HuR controls apoptosis and activation response without effects on cytokine 3' UTRs. Karginov FV. RNA Biol. 2019 May;16(5):686-695. doi: 10.1080/15476286.2019.1582954. Epub 2019 Mar 4. PubMed |
| Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia. Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, Hockemeyer K, Ghebrechristos YE, Yoshimi A, Inoue D, Ki M, Cho H, Bitner L, Kloetgen A, Lin KT, Uehara T, Owa T, Tibes R, Krainer AR, Abdel-Wahab O, Aifantis I. Cancer Cell. 2019 Mar 18;35(3):369-384.e7. doi: 10.1016/j.ccell.2019.01.010. Epub 2019 Feb 21. PubMed |
| Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR. Zhu H, Bhatt B, Sivaprakasam S, Cai Y, Liu S, Kodeboyina SK, Patel N, Savage NM, Sharma A, Kaufman RJ, Li H, Singh N. Nat Commun. 2019 Mar 6;10(1):1084. doi: 10.1038/s41467-019-08908-5. PubMed |
| MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer. Yi J, Liu C, Tao Z, Wang M, Jia Y, Sang X, Shen L, Xue Y, Jiang K, Luo F, Liu P, Cheng H. EBioMedicine. 2019 May;43:225-237. doi: 10.1016/j.ebiom.2019.03.027. Epub 2019 Mar 18. PubMed |
| MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Poole CJ, Lodh A, Choi JH, van Riggelen J. Epigenetics Chromatin. 2019 Jul 2;12(1):41. doi: 10.1186/s13072-019-0278-5. PubMed |
| P11 Loss-of-Function is Associated with Decreased Cell Proliferation and Neurobehavioral Disorders in Mice. Liu G, Wang Y, Zheng W, Cheng H, Zhou R. Int J Biol Sci. 2019 May 20;15(7):1383-1395. doi: 10.7150/ijbs.33773. eCollection 2019. PubMed |
| Phenotype instability of hepatocyte-like cells produced by direct reprogramming of mesenchymal stromal cells. Orge ID, Gadd VL, Barouh JL, Rossi EA, Carvalho RH, Smith I, Allahdadi KJ, Paredes BD, Silva DN, Damasceno PKF, Sampaio GL, Forbes SJ, Soares MBP, Souza BSF. Stem Cell Res Ther. 2020 Apr 10;11(1):154. doi: 10.1186/s13287-020-01665-z. PubMed |
| Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8(+) T Cells. Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, LaFleur MW, Ringel AE, Yao CH, Kurmi K, Juneja VR, Trombley JD, Haigis MC, Sharpe AH. Cancer Immunol Res. 2021 Feb;9(2):184-199. doi: 10.1158/2326-6066.CIR-20-0384. Epub 2020 Dec 4. PubMed |
| Simultaneous Inhibition of LSD1 and TGFbeta Enables Eradication of Poorly Immunogenic Tumors with Anti-PD-1 Treatment. Sheng W, Liu Y, Chakraborty D, Debo B, Shi Y. Cancer Discov. 2021 Aug;11(8):1970-1981. doi: 10.1158/2159-8290.CD-20-0017. Epub 2021 Mar 9. PubMed |
| JMJD6 Dysfunction Due to Iron Deficiency in Preeclampsia Disrupts Fibronectin Homeostasis Resulting in Diminished Trophoblast Migration. Alahari S, Farrell A, Ermini L, Park C, Sallais J, Roberts S, Gillmore T, Litvack M, Post M, Caniggia I. Front Cell Dev Biol. 2021 May 12;9:652607. doi: 10.3389/fcell.2021.652607. eCollection 2021. PubMed |
| EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Kim HR, Yim J, Yoo HB, Lee SE, Oh S, Jung S, Hwang CI, Shin DM, Kim T, Yoo KH, Kim YS, Lee HW, Roe JS. NAR Cancer. 2021 Jun 17;3(2):zcab023. doi: 10.1093/narcan/zcab023. eCollection 2021 Jun. PubMed |
Growth cone advance requires EB1 as revealed by genomic replacement with a light-sensitive variant.
Dema A, Charafeddine R, Rahgozar S, van Haren J, Wittmann T.
Elife. 2023 Jan 30;12:e84143. doi: 10.7554/eLife.84143.
PubMed
Associated Plasmids |
| Protocol for quantitative evaluation of the impact of paracrine senescence on cellular reprogramming in cultured cells and mouse models. Chantrel J, Chen C, Zhang J, Li H. STAR Protoc. 2023 Feb 7;4(1):102106. doi: 10.1016/j.xpro.2023.102106. PubMed |
| Characterizing asparagine synthetase deficiency variants in lymphoblastoid cell lines. Staklinski SJ, Chang MC, Ahrens-Nicklas RC, Kaur S, Stefanatos AK, Dudenhausen EE, Merritt ME, Kilberg MS. JIMD Rep. 2023 Jan 5;64(2):167-179. doi: 10.1002/jmd2.12356. eCollection 2023 Mar. PubMed |
| BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8(+) T cell infiltration in colorectal cancer. Li W, Zhao C, Li W, Gong Y, Ma K, Lu Y, Liu X, Zhang L, Guo F. J Transl Med. 2023 Oct 18;21(1):737. doi: 10.1186/s12967-023-04606-5. PubMed |
| Accessory subunit NDUFB4 participates in mitochondrial complex I supercomplex formation. Parmar G, Fong-McMaster C, Pileggi CA, Patten DA, Cuillerier A, Myers S, Wang Y, Hekimi S, Cuperlovic-Culf M, Harper ME. J Biol Chem. 2024 Feb;300(2):105626. doi: 10.1016/j.jbc.2024.105626. Epub 2024 Jan 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.